-
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story
18 Jun 2025 20:14 GMT
… record-high medical cannabis revenue, adjusted EBITDA and positive … it to come back in Q2. We expect to be … revenue and nearly 90% of its gross profit.
"All of the profitability …
"Because these are pharmaceutical products, we believe that the …
-
Indies Pharma sales, profit singed by delays and Mideast volatility
18 Jun 2025 09:03 GMT
… profit at Indies Pharma Jamaica Limited.
For the second quarter ended April, profit … $64 million, while revenue fell by one-tenth … Muppuri said the pharmaceutical distribution company experienced … He estimates that the second quarter delays cost the company …
-
Indies Pharma reports mixed results for 2nd quarter
16 Jun 2025 13:56 GMT
Indies Pharma Jamaica has reported mixed results for its second quarter ending April … 30, 2025.
Net profit for the … 6.5 million, as revenues also declined by 10 per … J$270 million.
Gross profit for the three-month period …
-
1933 Industries Reports Profit in Third Quarter 2025 Financial Results
16 Jun 2025 13:52 GMT
… a 7% increase from Q2, signalling sustained growth
Net … CONSOLIDATED OPERATING FINANCIAL HIGHLIGHTS
Revenue
Revenue was $4.7 million … calculated as gross profit divided by revenue was 53% in … wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist …
-
Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch
15 Jun 2025 00:20 GMT
… the last quarter. Verona Pharma plc (NASDAQ:VRNA) continues … the company’s profitability in the second quarter is just the … cherry on top. Jim Cramer Notes Verona Pharma … disease. Some believe that Verona Pharma plc (NASDAQ:VRNA) is …
-
Cell Culture Market Growth Driven by Cancer Research | Expected to Reach $36,926.8 Million
19 Jun 2025 06:56 GMT
Cell culture is defined as a process of removing cells from an animal or plant source and growing subsequently under controlled conditions (in vitro).
PORTLAND, OR, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- Cell culture refers to the …
-
US close: Stocks flat on Fed caution, geopolitical uncertainty
19 Jun 2025 06:54 GMT
…
Steel producer Nucor gained after second-quarter earnings guidance impressed the market … 6% after beating both revenue and profit estimates for its fourth quarter … ) $322.05 1.80%
Vertex Pharmaceuticals Inc. (VRTX) $448.40 1 …
-
Wall Street Live: S&P 500, Dow Jones, Nasdaq gain ahead of Fed interest rate decision
18 Jun 2025 15:58 GMT
… advanced 4.9% after a second quarter profit forecast.
Shares of chipmaker Marvell … for dollar-pegged cryptocurrency tokens.
Drugmaker Scholar Rock shares climbed 17 …
-
Wall Street edged higher ahead of Fed’s interest rate verdict
18 Jun 2025 14:49 GMT
… rose 17.4% after the drugmaker said its experimental drug helped … rose 4.9% following a second-quarter profit forecast that came above analysts …
-
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
18 Jun 2025 11:50 GMT
Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 million
Prenetics simplifies investment thesis as company focuses on high-growth consumer health brands IM8, …
About
© 1995-2025